Expeditors (EXPD) Form 4: Routine Dividend Rights Award to SVP Dickerman
Rhea-AI Filing Summary
Expeditors International of Washington, Inc. (EXPD) filed a Form 4 on 18 June 2025 disclosing insider activity by Jeffrey F. Dickerman, the company’s Senior Vice President, General Counsel and Corporate Secretary.
Non-derivative holdings: Following the reported transactions, Dickerman directly owns 8,948.2771 common shares. The filing does not list any open-market purchase or sale of common stock; therefore the share count reflects prior holdings plus routine adjustments.
Derivative activity: On 16 June 2025, Dickerman automatically received dividend-equivalent rights (DERs) linked to previously granted restricted stock units (RSUs):
- 2023 RSU grant: 5.243 DERs acquired
- 2024 RSU grant: 10.211 DERs acquired
- 2025 RSU grant: 19.586 DERs acquired
Each DER represents the economic value of one common share and vests proportionately with the underlying RSUs. The reference price disclosed for the DERs is $115.11, matching EXPD’s dividend valuation date. After the award, the executive holds 24.104, 28.66 and 19.586 DERs linked to the 2023, 2024 and 2025 RSU tranches, respectively.
Materiality assessment: The cumulative addition of 35.04 share-equivalent units is immaterial relative to EXPD’s 158 million outstanding shares and does not signal a directional view. The filing appears to be a routine dividend-accrual update rather than an active purchase or sale.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 4 shows small dividend-equivalent accruals; no open-market buying or selling, therefore negligible impact on EXPD valuation.
The award of 35.04 DERs is purely mechanical, triggered by the company’s cash dividend on outstanding RSUs. Because these rights vest in line with existing RSU schedules, they do not alter near-term share count, cash flow or insider sentiment. Dickerman’s direct stock ownership remains below 9,000 shares, unchanged from prior filings except for dividend adjustments. From a governance standpoint, the filing satisfies Section 16 compliance but offers no new insight into management’s outlook or capital strategy. Investors can treat this as administrative.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights - 2023 RSUs | 5.243 | $115.11 | $603.52 |
| Grant/Award | Dividend Equivalent Rights - 2024 RSUs | 10.211 | $115.11 | $1K |
| Grant/Award | Dividend Equivalent Rights - 2025 RSUs | 19.586 | $115.11 | $2K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2023 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2024 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one common share of the Issuer. The dividend equivalent rights accrued in respect of the 2025 grant of restricted stock units and vest proportionately with the restricted stock units to which they relate.
FAQ
Who filed the latest Form 4 for EXPD on 18 June 2025?
What derivative securities were reported in the EXPD Form 4?
Was there any open-market purchase or sale by the insider?
What reference price was assigned to the dividend-equivalent rights?